156 related articles for article (PubMed ID: 37967926)
1. Treatment-induced neuropathy of diabetes: challenges in diagnosing neuropathic pain, value of sudomotor function testing.
Abdelhamid S; Shabani M; Russjan A; Tarnutzer AA
BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 37967926
[TBL] [Abstract][Full Text] [Related]
2. Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison.
Tanenberg RJ; Irving GA; Risser RC; Ahl J; Robinson MJ; Skljarevski V; Malcolm SK
Mayo Clin Proc; 2011 Jul; 86(7):615-26. PubMed ID: 21719618
[TBL] [Abstract][Full Text] [Related]
3. Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: data from the randomized, double-blind, COMBO-DN study.
Bouhassira D; Wilhelm S; Schacht A; Perrot S; Kosek E; Cruccu G; Freynhagen R; Tesfaye S; Lledó A; Choy E; Marchettini P; Micó JA; Spaeth M; Skljarevski V; Tölle T
Pain; 2014 Oct; 155(10):2171-9. PubMed ID: 25168665
[TBL] [Abstract][Full Text] [Related]
4. Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT.
Tesfaye S; Sloan G; Petrie J; White D; Bradburn M; Young T; Rajbhandari S; Sharma S; Rayman G; Gouni R; Alam U; Julious SA; Cooper C; Loban A; Sutherland K; Glover R; Waterhouse S; Turton E; Horspool M; Gandhi R; Maguire D; Jude E; Ahmed SH; Vas P; Hariman C; McDougall C; Devers M; Tsatlidis V; Johnson M; Bouhassira D; Bennett DL; Selvarajah D
Health Technol Assess; 2022 Oct; 26(39):1-100. PubMed ID: 36259684
[TBL] [Abstract][Full Text] [Related]
5. [Diabetic asymmetric proximal neuropathy].
Kotov SV; Rudakova IG; Isakova EV; Belova YA; Volchenkova TV; Khirbek M; Stashuk GA
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(1):59-62. PubMed ID: 28252606
[TBL] [Abstract][Full Text] [Related]
6. Multicentre, double-blind, crossover trial to identify the Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus (OPTION-DM): study protocol for a randomised controlled trial.
Selvarajah D; Petrie J; White D; Julious S; Bortolami O; Cooper C; Bradburn M; Loban A; Bowler H; Swaby L; Sutherland K; Tesfaye S;
Trials; 2018 Oct; 19(1):578. PubMed ID: 30348206
[TBL] [Abstract][Full Text] [Related]
7. Burning through the pain: treatments for diabetic neuropathy.
Javed S; Alam U; Malik RA
Diabetes Obes Metab; 2015 Dec; 17(12):1115-25. PubMed ID: 26179288
[TBL] [Abstract][Full Text] [Related]
8. CIDP variants in diabetes: measuring treatment response with a small nerve fiber test.
Névoret ML; Vinik AI
J Diabetes Complications; 2015 Mar; 29(2):313-7. PubMed ID: 25466645
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Pregabalin Compared to Duloxetine in Diabetic Peripheral Neuropathic Pain: An Observational Study.
Jha S; Sahani OP; Siddiqui S; Verma MK; Mazumder A; Waghdhare S
J Assoc Physicians India; 2019 Nov; 67(11):32-36. PubMed ID: 31793266
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic management of diabetic peripheral neuropathic pain.
Iyer S; Tanenberg RJ
Expert Opin Pharmacother; 2013 Sep; 14(13):1765-75. PubMed ID: 23800105
[TBL] [Abstract][Full Text] [Related]
11. Duloxetine and pregabalin in neuropathic pain of lung cancer patients.
Gül ŞK; Tepetam H; Gül HL
Brain Behav; 2020 Mar; 10(3):e01527. PubMed ID: 31967742
[TBL] [Abstract][Full Text] [Related]
12. Duloxetine in Painful Diabetic Neuropathy: A Systematic Review.
Hossain SM; Hussain SM; Ekram AR
Clin J Pain; 2016 Nov; 32(11):1005-1010. PubMed ID: 26710221
[TBL] [Abstract][Full Text] [Related]
13. Amitriptyline, Duloxetine, and Pregabalin Each Effective in Decreasing Pain From Diabetic Peripheral Neuropathy; Combinations Even Better.
Barry HC
Am Fam Physician; 2023 Mar; 107(3):316-317. PubMed ID: 36920835
[No Abstract] [Full Text] [Related]
14. A comparative double-blind randomized study on the effectiveness of Duloxetine and Gabapentin on painful diabetic peripheral polyneuropathy.
Majdinasab N; Kaveyani H; Azizi M
Drug Des Devel Ther; 2019; 13():1985-1992. PubMed ID: 31354243
[No Abstract] [Full Text] [Related]
15. Painful diabetic neuropathy.
Peltier A; Goutman SA; Callaghan BC
BMJ; 2014 May; 348():g1799. PubMed ID: 24803311
[TBL] [Abstract][Full Text] [Related]
16. Treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomised trial of duloxetine vs. placebo.
Gao Y; Guo X; Han P; Li Q; Yang G; Qu S; Yue L; Wang CN; Skljarevski V; Dueñas H; Raskin J; Gu L
Int J Clin Pract; 2015 Sep; 69(9):957-66. PubMed ID: 25939897
[TBL] [Abstract][Full Text] [Related]
17. Duloxetine for the treatment of painful diabetic peripheral neuropathy in Venezuela: economic evaluation.
Carlos F; Espejel L; Novick D; López R; Flores D
Medwave; 2015 Sep; 15(8):e6265. PubMed ID: 26460688
[TBL] [Abstract][Full Text] [Related]
18. Retrospective chart review of duloxetine and pregabalin in the treatment of painful neuropathy.
Mittal M; Pasnoor M; Mummaneni RB; Khan S; McVey A; Saperstein D; Herbelin L; Ridings L; Wang Y; Dimachkie MM; Barohn RJ
Int J Neurosci; 2011 Sep; 121(9):521-7. PubMed ID: 21671841
[TBL] [Abstract][Full Text] [Related]
19. Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes.
Gibbons CH; Freeman R
Brain; 2015 Jan; 138(Pt 1):43-52. PubMed ID: 25392197
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy for painful diabetic neuropathy is safe and effective.
Saul H; Deeney B; Imison C; Tesfaye S
BMJ; 2023 Apr; 381():866. PubMed ID: 37085164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
